Metformin Induces Apoptosis and Inhibits Notch1 in Malignant Pleural Mesothelioma Cells
Open Access
- 18 January 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
Malignant pleural mesothelioma (MPM) is an aggressive asbestos-related cancer arising from the mesothelial cells lining the pleural cavity. MPM is characterized by a silent clinical progression and a highly resistance to conventional chemo/radio-therapies. MPM patients die in a few months/years from diagnosis. Notch signaling is a well-conserved cell communication system, which regulates many biological processes. In humans, the dysregulation of Notch pathway potentially contributes to cancer onset/progression, including MPM. Metformin is the first-line drug used to treat type 2 diabetes mellitus. Metformin is proven to be an effective antitumor drug in preclinical models of different types of cancer. To date, clinical efficacy is being studied in many clinical trials. In this study, the anti-proliferative effect of metformin on MPM cells and the putative involvement of Notch1 as a mediator of metformin activities, were investigated. MPM cells showed high levels of Notch1 activation compared to normal pleural mesothelial cells. Furthermore, metformin treatment hampered MPM cell proliferation and enhanced the apoptotic process, accompanied by decreased Notch1 activation.Funding Information
- Associazione Italiana per la Ricerca sul Cancro
This publication has 58 references indexed in Scilit:
- High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesotheliomaProceedings of the National Academy of Sciences of the United States of America, 2012
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysisPLOS ONE, 2012
- Germline BAP1 mutations predispose to malignant mesotheliomaNature Genetics, 2011
- MicroRNAs Dysregulation in Human Malignant Pleural MesotheliomaJournal of Thoracic Oncology, 2011
- Metformin Induces Both Caspase-Dependent and Poly(ADP-ribose) Polymerase-Dependent Cell Death in Breast Cancer CellsMolecular Cancer Research, 2011
- Malignant mesothelioma: Facts, Myths, and HypothesesJournal of Cellular Physiology, 2011
- Diabetes and CancerDiabetes Care, 2010
- Noxa: at the tip of the balance between life and deathOncogene, 2008
- A Novel Mechanism of Late Gene Silencing Drives SV40 Transformation of Human Mesothelial CellsCancer Research, 2008
- Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cellsOncogene, 2003